ASC

Fujifilm Showcases New Endoscopy Innovations for the Detection, Diagnosis, and Treatment of Diseases at Digestive Disease Week 2022

Retrieved on: 
Tuesday, May 17, 2022 - 2:48pm

Fujifilm will showcase its entire portfolio of endoscopic imaging solutions for core gastrointestinal (GI), therapeutic, interventional, and third space endoscopy in booth 4343.

Key Points: 
  • Fujifilm will showcase its entire portfolio of endoscopic imaging solutions for core gastrointestinal (GI), therapeutic, interventional, and third space endoscopy in booth 4343.
  • New to DDW this year, Fujifilm will demonstrate:
    ELUXEO VISION is Fujifilms new image enhancement technology developed to improve visualization during GI, colorectal, and advanced endoscopy and surgical procedures.
  • The new image enhancement technology enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue using laparoscopic and/or endoscopic imaging.
  • Being able to detect StO2 levels helps surgeons identify potentially ischemic tissue, better positioning them to prevent tissue necrosis.

LeaseQuery Forms New Reseller Partnership With Cherry Bekaert

Retrieved on: 
Tuesday, May 17, 2022 - 2:03pm

LeaseQuery , a leading provider of software built to simplify the complexities of accounting, today announced a reseller partnership with Cherry Bekaert LLP, a leading accounting and advisory firm offering specialized solutions across various industries.

Key Points: 
  • LeaseQuery , a leading provider of software built to simplify the complexities of accounting, today announced a reseller partnership with Cherry Bekaert LLP, a leading accounting and advisory firm offering specialized solutions across various industries.
  • LeaseQuery has partnered with Cherry Bekaert as a select reseller for its lease accounting software.
  • As a reseller, Cherry Bekaert can now offer its clients a trusted solution that takes lease accounting through mandatory compliance with government regulations and beyond.
  • Cherry Bekaert is excited to enhance and further grow our relations with LeaseQuery, said Christian Fuellgraf, Government & Public Sector Leader and Principal, Advisory Services.

Light & Wonder Provides Business Strategy Details and Long-Term Targets at 2022 Investor Day

Retrieved on: 
Tuesday, May 17, 2022 - 1:45pm

(2) We entered into certain cross-currency interest rate swap agreements to achieve more attractive interest rates by effectively converting $460 million of the fixed-rate, U.S.

Key Points: 
  • (2) We entered into certain cross-currency interest rate swap agreements to achieve more attractive interest rates by effectively converting $460 million of the fixed-rate, U.S.
  • (3) Primarily comprised of certain revenue transactions presented as debt in accordance with ASC 470.
  • The forward-looking non-GAAP financial measure targeted Consolidated AEBITDA represents a goal for the Company and does not reflect Company guidance.
  • The forward-looking non-GAAP financial measure targeted net debt leverage ratio represents a goal for the Company and does not reflect Company guidance.

Heliogen to Restate Full Year 2021 Financials

Retrieved on: 
Tuesday, May 17, 2022 - 1:19am

Heliogen, Inc. (the Company) (NYSE:HLGN), a leading provider of AI-enabled concentrated solar energy technology, today announced that it will restate its full-year 2021 financial statements.

Key Points: 
  • Heliogen, Inc. (the Company) (NYSE:HLGN), a leading provider of AI-enabled concentrated solar energy technology, today announced that it will restate its full-year 2021 financial statements.
  • The call can also be accessed live via telephone by dialing 1-877-407-0789 (1-201-689-8562 for international callers) and referencing Heliogen.
  • Heliogen, Inc. is a renewable energy technology company focused on eliminating the need for fossil fuels in heavy industry and powering a sustainable future.
  • Heliogen was created at Idealab, the leading technology incubator founded by Bill Gross in 1996.

ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine Models for Novel Gene Therapy in Maple Syrup Urine Disease at the 25th ASGCT Meeting

Retrieved on: 
Tuesday, May 17, 2022 - 1:00am

The partnership designed a dual-function AAV9 gene replacement vector that was administered via intravenous (IV) injection.

Key Points: 
  • The partnership designed a dual-function AAV9 gene replacement vector that was administered via intravenous (IV) injection.
  • Surviving mice grew and behaved similar to normal littermates and had normal or nearly normal biochemical markers with unrestricted diet for 16 weeks.
  • As compared to MSUD patients, MSUD calves exhibit a similar phenotype and are closely matched for size and metabolic rate.
  • In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education.

ASC Therapeutics Announces Podium and Poster Presentations of IND-Enabling Studies for ASC618, a Second-Generation Gene Therapy for Hemophilia A, at the 25th ASGCT Meeting, May 16-19, 2022 in Washington, D.C.

Retrieved on: 
Tuesday, May 17, 2022 - 1:00am

These studies were included in a filing to the U.S. Food and Drug Administration (FDA) leading to IND clearance of ASC618 .

Key Points: 
  • These studies were included in a filing to the U.S. Food and Drug Administration (FDA) leading to IND clearance of ASC618 .
  • We are thrilled to bring a second-generation gene therapy treatment to patients with Hemophilia A.
  • Thousands of cell and gene therapy developers, including basic and clinical investigators represent the academic, regulatory, and biotechnology sectors.
  • Hemophilia A gene therapy: current and next-generation approaches, Expert Opinion on Biological Therapy 2022 Jan 6;1-17, DOI: 10.1080/14712598.2022.2002842
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220516005908/en/

Super League Gaming Reports Record First Quarter 2022 Results

Retrieved on: 
Monday, May 16, 2022 - 9:05pm

SANTA MONICA, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Super League Gaming (Super League or the Company) (Nasdaq: SLGG), a leading network of metaverse games, monetization tools, and content channels, reported financial results and recent operational developments for the first quarter ended March 31, 2022.

Key Points: 
  • SANTA MONICA, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Super League Gaming (Super League or the Company) (Nasdaq: SLGG), a leading network of metaverse games, monetization tools, and content channels, reported financial results and recent operational developments for the first quarter ended March 31, 2022.
  • The momentum from our record-setting year in 2021 certainly continued into the first quarter of 2022, said Ann Hand, CEO of Super League Gaming.
  • Given the solid foundation set by our strong first quarter results, we believe we are well-positioned to achieve our plan and growth expectations for 2022.
  • First quarter 2022 cost of revenues increased to $1.9 million compared to $342,000 in the comparable prior year quarter.

Firsthand Technology Value Fund Announces First Quarter Financial Results, NAV of $12.68 per share

Retrieved on: 
Monday, May 16, 2022 - 9:15pm

For the three months ended March 31, 2022, the Fund reported investment income of approximately $1.9 million.

Key Points: 
  • For the three months ended March 31, 2022, the Fund reported investment income of approximately $1.9 million.
  • The Fund reported net realized and unrealized losses on investments of approximately $8.6 million for the quarter.
  • Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
  • Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies.

DEADLINE ALERT for CELH, GRAB, and CANO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, May 16, 2022 - 4:00pm

LOS ANGELES, May 16, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, May 16, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com .
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE ALERT for CELH, GRAB, CANO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, May 16, 2022 - 5:00pm

BENSALEM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.